ai² Futures Lab™ is an innovation initiative under Lōkahi’s ai² platform
We partner with leading universities to give students hands-on exposure to the strategic side of biopharma—from evaluating clinical assets to understanding intellectual property, market dynamics, and go-to-market strategies.
ai² Futures Lab isn’t about textbooks—it’s about impact. Together, students and Lōkahi mentors explore how breakthrough science becomes breakthrough therapies.
Student Teams Identify & Evaluate Deprioritized or Distressed Clinical Assets in 3 Comprehensive Stages
-
Clinical Review
Comprehensive analysis of existing clinical trial data to assess efficacy & safety profiles paired with an evaluation of the current IP profile of the distressed asset serves as the first stage of screening.
-
Market Analysis
Deep dive into the commercial viability of the asset consisting of thorough market size evaluation, marketed competitive analysis, developmental competitive analysis, and potential opportunity therein.
-
Financial Outlook
Evaluation of the potential financial benefit of the asset. Capture the process of drug pricing, potential revenue, peak sales forecasting, and estimated ramp up from penetration to peak.
Each Output is Evaluated for Potential Integration into Lōkahi’s Asset Pipeline
What Students Gain
Experience applying classroom knowledge to real-world biopharma challenges.
Exposure to clinical development, intellectual property, market analysis, and commercialization strategy.
Opportunities for paid internships, consulting projects, or employment with Lōkahi.
Direct influence on potential Lōkahi pipeline decisions.
Current Collaborations
Testimonials
-
“Our students will gain invaluable exposure to the business side of the life sciences industry. Partnering with Lōkahi allows us to deliver a one-of-a-kind experience—where academic rigor meets real-world biopharma decision-making.”
Jaime Alonso Gomez, Ph.D.
Professor of Strategy, International Management and Family Business at the Knauss School of Business at the University of San Diego -
"This semester was such a valuable experience for me. Working with the Lōkahi team helped me grow not only in my understanding of the pharmaceutical industry, but also in my confidence as a future business leader. The guidance and feedback I received pushed me outside my comfort zone and gave me the opportunity to step up and lead a team. I’m incredibly grateful for the mentorship and support, and for the chance to learn from people who genuinely wanted to see us succeed."
Ria Pearson-Ybarra
MBA Candidate, University of Alabama -
“Our students will gain unique experience contributing to the success of a biopharma company. This program provides a one-of-a-kind opportunity to bring the business of biotechnology to a new generation of leaders.”
Rob Morgan, Ph.D.
Director of the STEM Path and CREATE Path to the MBA programs at The University of Alabama
Key Advisors
-
Brian
Program Lead
Expertise: Program Development, Commercialization Efforts -
Erik
Advisor
Expertise: Company Vision, Executive Leadership -
Coben
Advisor
Expertise: Finance, Real World Experience programs -
Susan
Advisor
Expertise: Asset Identification, Clinical Development -
Kim
Advisor
Expertise: Legal, Intellectual Property -
Greg
Advisor
Expertise: Asset Identification, Business Development
Be our Partner Today
Interested in partnering with Lōkahi Therapeutics through the ai² Futures Lab? Use the form to connect with our team and start a conversation about potential collaboration.